Cardlytics Stock Today

CDLX Stock  USD 1.15  0.00  0.00%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

Strong

 
High
 
Low
Cardlytics is trading at 1.15 as of the 5th of January 2026; that is No Change since the beginning of the trading day. The stock's open price was 1.145. Cardlytics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 6th of December 2025 and ending today, the 5th of January 2026. Click here to learn more.
Business Domain
Media & Entertainment
IPO Date
9th of February 2018
Category
Communication Services
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Cardlytics operates under Advertising Agencies classification in the United States and is traded on NASDAQ Exchange. The company has 54.06 M outstanding shares of which 5.23 M shares are currently shorted by private and institutional investors with about 6.98 trading days to cover. More on Cardlytics

Moving together with Cardlytics Stock

  0.9003010 Guangzhou RuoyuchenPairCorr

Moving against Cardlytics Stock

  0.82300058 BlueFocus CommunicationPairCorr
  0.77300071 Spearhead IntegratedPairCorr
  0.66INTJ Intelligent GroupPairCorr
  0.49603598 Inly MediaPairCorr
  0.45000917 Hunan TV BroadcastPairCorr
  0.39605168 Threes CompanyPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Cardlytics Stock Highlights

CEO DirectorAmit Gupta
Business ConcentrationAdvertising, Media & Entertainment, Communication Services, NASDAQ Composite, Nasdaq Industrial, Communication Services, Media, Advertising Agencies, Communication Services (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.860.81
Notably Up
Slightly volatile
Gross Profit Margin0.30.39
Way Down
Slightly volatile
Total Current Liabilities138.3 M171.3 M
Significantly Down
Slightly volatile
Non Current Liabilities Total205 M199.8 M
Fairly Up
Pretty Stable
Total Assets439.2 M451.6 M
Fairly Down
Slightly volatile
Total Current Assets212 M204.7 M
Sufficiently Up
Slightly volatile
Debt Levels
Cardlytics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cardlytics' financial leverage. It provides some insight into what part of Cardlytics' total assets is financed by creditors.
Liquidity
Cardlytics currently holds 221.65 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Cardlytics has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Cardlytics' use of debt, we should always consider it together with its cash and equity.

Depreciation

18.22 Million
Cardlytics (CDLX) is traded on NASDAQ Exchange in USA and employs 367 people. Cardlytics is listed under Advertising category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 60.54 M. Cardlytics conducts business under Media sector and is part of Communication Services industry. The entity has 54.06 M outstanding shares of which 5.23 M shares are currently shorted by private and institutional investors with about 6.98 trading days to cover. Cardlytics currently holds about 157.04 M in cash with (8.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Cardlytics Probability Of Bankruptcy
Ownership Allocation
Cardlytics holds a total of 54.06 Million outstanding shares. 30% of Cardlytics outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cardlytics Ownership Details

Cardlytics Stock Institutional Holders

InstituionRecorded OnShares
D. E. Shaw & Co Lp2025-06-30
504.9 K
Bank Of America Corp2025-06-30
410.2 K
Landscape Capital Management,llc2025-06-30
400 K
Gsa Capital Partners Llp2025-06-30
358.6 K
Acorn Financial Advisory Services Inc2025-06-30
326.2 K
Morgan Stanley - Brokerage Accounts2025-06-30
325.5 K
Dimensional Fund Advisors, Inc.2025-06-30
309.3 K
Charles Schwab Investment Management Inc2025-06-30
269.7 K
Brooktree Capital Management Inc2025-06-30
242.2 K
Vanguard Group Inc2025-06-30
2.4 M
683 Capital Management Llc2025-06-30
1.6 M
View Cardlytics Diagnostics

Cardlytics Historical Income Statement

At this time, Cardlytics' Interest Income is fairly stable compared to the past year. Selling And Marketing Expenses is likely to rise to about 51.5 M in 2026, whereas Depreciation And Amortization is likely to drop slightly above 18.2 M in 2026. View More Fundamentals

Cardlytics Stock Against Markets

Cardlytics Corporate Management

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.